Fernandez, Janine May B.
HRN: 21-29-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
CEFTRIAXONE 1G (VIAL)
05/02/2022
05/08/2022
IV DRIP X 1 HOUR
2 Grams
Q12
Pleural Effusion Vs Consolidation
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes